ES2192426A1 - Anticuerpo monoclonal humano sm50/20 que reconoce leucocitos humanos, y su uso en terapia. - Google Patents

Anticuerpo monoclonal humano sm50/20 que reconoce leucocitos humanos, y su uso en terapia.

Info

Publication number
ES2192426A1
ES2192426A1 ES200001194A ES200001194A ES2192426A1 ES 2192426 A1 ES2192426 A1 ES 2192426A1 ES 200001194 A ES200001194 A ES 200001194A ES 200001194 A ES200001194 A ES 200001194A ES 2192426 A1 ES2192426 A1 ES 2192426A1
Authority
ES
Spain
Prior art keywords
human
monoclonal antibody
leucocytes
hybridoma obtained
immunized mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200001194A
Other languages
English (en)
Other versions
ES2192426B1 (es
Inventor
Fernandez Africa Gonzalez
Mompo Susana Magadan
Ocana Ana Molina
Deza Francisco Gambon
Andrade Monica Valladares
Marianne Bruggemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Vigo
Original Assignee
Universidade de Vigo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Vigo filed Critical Universidade de Vigo
Priority to ES200001194A priority Critical patent/ES2192426B1/es
Publication of ES2192426A1 publication Critical patent/ES2192426A1/es
Application granted granted Critical
Publication of ES2192426B1 publication Critical patent/ES2192426B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención corresponde a Hibridoma productor de un anticuerpo monoclonal humano SM 50/20 (isotipo IgM / kappa) con cadenas pesadas y ligeras humanas. El anticuerpo reconoce un antígeno específico (peso molecular 150-180 Kd.) presente en linfocitos T y linfocitos B, monocitos, granulocitos, líneas tumorales humanas tipo B y T, y leucemias humanas linfoides crónicas, y algunas mieloides. El hibridoma se obtuvo de linfocitos B de ratones inmunizados con leucocitos humanos fusionados con células de mieloma murino SP2/0, posterior clonación y seleccionado en base a su secreción de anticuerpos por ELISA y a su patrón de reconocimiento celular por inmunofluorescencia indirecta. Los ratones inmunizados son transgénicos, portadores de genes de inmunoglobulinas humanas (m y k )y carecen de los genes murinos de cadenas pesadas y ligera kappa. La presente invención podría utilizarse para detección y/o tratamiento de patología linfoide humana (leucemia linfoide crónica, linfomas y otras patologías del sistema hematológico).
ES200001194A 2000-05-11 2000-05-11 Anticuerpo monoclonal humano sm50/20 que reconoce leucocitos humanos, y su uso en terapia. Expired - Fee Related ES2192426B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200001194A ES2192426B1 (es) 2000-05-11 2000-05-11 Anticuerpo monoclonal humano sm50/20 que reconoce leucocitos humanos, y su uso en terapia.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200001194A ES2192426B1 (es) 2000-05-11 2000-05-11 Anticuerpo monoclonal humano sm50/20 que reconoce leucocitos humanos, y su uso en terapia.

Publications (2)

Publication Number Publication Date
ES2192426A1 true ES2192426A1 (es) 2003-10-01
ES2192426B1 ES2192426B1 (es) 2005-02-16

Family

ID=29762849

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200001194A Expired - Fee Related ES2192426B1 (es) 2000-05-11 2000-05-11 Anticuerpo monoclonal humano sm50/20 que reconoce leucocitos humanos, y su uso en terapia.

Country Status (1)

Country Link
ES (1) ES2192426B1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10259874B2 (en) 2014-10-27 2019-04-16 Agency For Science, Technology And Research Anti-TIM-3 antibodies
US10435466B2 (en) 2014-10-27 2019-10-08 Agency For Science, Technology And Research Anti-TIM-3 antibodies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033735A1 (en) * 1995-04-27 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
ES2115626T3 (es) * 1991-06-28 1998-07-01 Mitsubishi Chem Corp Anticuerpo monoclonal humano especifico al antigeno de superficie de la membrana de las celulas cancerosas.
US5877397A (en) * 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
WO1999045962A1 (en) * 1998-03-13 1999-09-16 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877397A (en) * 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ES2115626T3 (es) * 1991-06-28 1998-07-01 Mitsubishi Chem Corp Anticuerpo monoclonal humano especifico al antigeno de superficie de la membrana de las celulas cancerosas.
WO1996033735A1 (en) * 1995-04-27 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1999045962A1 (en) * 1998-03-13 1999-09-16 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10259874B2 (en) 2014-10-27 2019-04-16 Agency For Science, Technology And Research Anti-TIM-3 antibodies
US10435466B2 (en) 2014-10-27 2019-10-08 Agency For Science, Technology And Research Anti-TIM-3 antibodies
US11142574B2 (en) 2014-10-27 2021-10-12 Agency For Science, Technology And Research Anti-TIM-3 antibodies

Also Published As

Publication number Publication date
ES2192426B1 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
EP0867451A3 (en) Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
EP1298144A3 (en) Murine monoclonal anti-idiotype antibody 3H1
IL123025A0 (en) Human monoclonal antibody against hepatitis b virus surface antigen (HBVSAG)
EP0743856A4 (en) ANTIG-OCCUPATING HETEROPOLYMERS AND METHODS FOR TREATING AUTOIMMUNE DISEASES BY MEANS OF THEM
KR910002468A (ko) 인간 인터로이킨-6 수용체에 대한 항체
ATE214423T1 (de) B-lymphomazellinie und antigen
HUP9904620A3 (en) Purified sperm surface antigen,monoclonal antibody therefor and applications therefor
NZ329314A (en) Hybridoma & method of preparing a monoclonal antibody reactive with hc gp-39, use & treatment of rheumatoid arthritis
EP0351045A3 (en) Monoclonal antibody nuh2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen
ES2192426A1 (es) Anticuerpo monoclonal humano sm50/20 que reconoce leucocitos humanos, y su uso en terapia.
IL94911A0 (en) Monoclonal antibodies directed against activated microglia cells,hybridomas secreting these monoclonal antibodies,antigen recognized by these monoclonal antibodies and their applications
ATE283927T1 (de) Monoklonale antikörper und antigene mit bezug zum menschlichen lungenadenokarzinom und immunoassay- verfahren unter verwendung desselben
PT733903E (pt) Processo de dosagem imunologica de cortisol nomeadamente urinario e reagentes utilizados
EP0759943A4 (en) MONOCLONAL ANTIBODIES SPECIFIC TO AN ENDOGLYX-1 ANTIGEN OF VASCULAR ENDOTHELIAL CELLS, THE ANTIGEN ITSELF AND USES THEREOF
EP0323802A3 (en) Monoclonal antibodies against, and cell surface antigen of, lung carcinoma
IL94912A0 (en) Monoclonal antibodies involved in alzheimer's disease,hybridomas secreting these monoclonal antibodies,antigen recognized by these antibodies,and their application
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
EP0369797A3 (en) A monoclonal antibody recognizing a reg protein
ES2009365A6 (es) Procedimiento de otencion de anticuerpos monoclonales para bacterias gram-negativas.
EP0347230A3 (en) Miniclones
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6
TW288020B (en) Monoclonal antibodies specific to methamphetamine, hybridoma producing the antibodies, kits containing the antibodies and uses thereof
ATE116372T1 (de) An krebszellen bindendes antigen.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20031001

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2192426B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20200826